Biomimetic nanoparticles represent a promising avenue for mitigating rapid clearance by the reticuloendothelial system (RES); however. current challenges include insufficient tumour targeting. suboptimal adhesion. and inadequate localized drug release within tumour regions. https://parisnaturalfoodes.shop/product-category/fiberrific/